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Acquisition of Avian Pathogenic Escherichia coli Plasmids by a
Commensal E. coli Isolate Enhances Its Abilities To Kill Chicken Embryos,
Grow in Human Urine, and Colonize the Murine Kidney
Abstract
We have found an avian pathogenic Escherichia coli (APEC) plasmid, pAPEC-O2-ColV, which contains many
of the genes associated with APEC virulence and also shows similarity in content to a plasmid and
pathogenicity island of human uropathogenic E. coli (UPEC). To test the possible role of this plasmid in
virulence, it was transferred by conjugation along with a large R plasmid, pAPEC-O2-R, into a commensal
avian E. coli strain. The transconjugant was compared to recipient strain NC, UPEC strain HE300, and donor
strain APEC O2 using various assays, including lethality for chicken embryos, growth in human urine, and
ability to cause urinary tract infection in mice. The transconjugant killed significantly more chicken embryos
than did the recipient. In human urine, APEC O2 grew at a rate equivalent to that of UPEC strain HE300, and
the transconjugant showed significantly increased growth compared to the recipient. The transconjugant also
significantly outcompeted the recipient in colonization of the murine kidney. These findings suggest that
APEC plasmids, such as pAPEC-O2-ColV, contribute to the pathogenesis of avian colibacillosis. Moreover,
since avian E. coli and their plasmids may be transmitted to humans, evaluation of APEC plasmids as possible
reservoirs of urovirulence genes for human UPEC may be warranted.
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We have found an avian pathogenic Escherichia coli (APEC) plasmid, pAPEC-O2-ColV, which contains many
of the genes associated with APEC virulence and also shows similarity in content to a plasmid and pathoge-
nicity island of human uropathogenic E. coli (UPEC). To test the possible role of this plasmid in virulence, it
was transferred by conjugation along with a large R plasmid, pAPEC-O2-R, into a commensal avian E. coli
strain. The transconjugant was compared to recipient strain NC, UPEC strain HE300, and donor strain APEC
O2 using various assays, including lethality for chicken embryos, growth in human urine, and ability to cause
urinary tract infection in mice. The transconjugant killed significantly more chicken embryos than did the
recipient. In human urine, APEC O2 grew at a rate equivalent to that of UPEC strain HE300, and the
transconjugant showed significantly increased growth compared to the recipient. The transconjugant also
significantly outcompeted the recipient in colonization of the murine kidney. These findings suggest that APEC
plasmids, such as pAPEC-O2-ColV, contribute to the pathogenesis of avian colibacillosis. Moreover, since
avian E. coli and their plasmids may be transmitted to humans, evaluation of APEC plasmids as possible
reservoirs of urovirulence genes for human UPEC may be warranted.
Avian colibacillosis, which is caused by avian pathogenic
Escherichia coli (APEC), is one of the most significant and
widespread infectious diseases occurring in production birds. It
is responsible for large financial losses for the poultry industry
each year due to mortality, lost production, and condemna-
tions (1, 16, 17). A better understanding of the virulence mech-
anisms of the causative APEC strains is needed to guide the
development of preventive measures.
Large plasmids occur commonly among APEC strains (7, 37)
and may be a defining feature of the APEC pathotype (37).
Certain APEC plasmids harbor a number of virulence genes (8,
27, 52) and are transmissible to other bacterial strains by conju-
gation (8, 14, 27). Such putative virulence plasmids may cotrans-
fer with large multidrug resistance-encoding R plasmids, as seen
with pAPEC-O2-R and pAPEC-O2-ColV (27), which may pro-
vide a mechanism for their selection and maintenance among the
E. coli strains causing disease in production birds.
Despite the fact that these large plasmids contain many of
the genes or operons thought to contribute to E. coli virulence,
we and others have reported that their acquisition by E. coli
K-12 strains does not necessarily result in increased virulence
of the recipient (14, 25, 30). Ginns and colleagues (14) thought
that this phenomenon might be due to a deficiency in the
chromosomal background of the K-12 recipients, making them
ill suited to cause disease. Therefore, in this study, we used an
avian commensal E. coli strain (NC) as a recipient with the
idea that it would be better adapted for survival in the avian
host than a K-12 strain and would therefore provide a better
background in which to assess the contributions of these plas-
mids to virulence and also because curing APEC O2 of its
plasmids by standard methods (14, 18, 36) had proved prob-
lematic (data not shown).
To determine the contributions of pAPEC-O2-ColV and
pAPEC-O2-R to virulence, we used three different models to
compare the virulence of an APEC plasmid donor strain
(APEC O2), which contains pAPEC-O2-ColV and pAPEC-
O2-R; the recipient, an avian commensal E. coli strain (NC);
and their transconjugant (NC/pAPEC-O2). The models used
included a chicken embryo lethality assay, chosen because its
results have been shown to positively correlate with an isolate’s
ability to cause lethality in 3-week old chickens (32) and mor-
bidity and mortality in subcutaneous and intravenous chicken
challenge models (12). Also, lethality to chicken embryos is a
common characteristic of E. coli causing extraintestinal infec-
tions in humans (30). Additionally, since pAPEC-O2-ColV
shows considerable sequence homology to a plasmid and
pathogenicity island (PAI) of human uropathogenic E. coli
(UPEC) and since there is rising concern that UPEC may
colonize the human colon following ingestion of contaminated
* Corresponding author. Mailing address: Department of Veteri-
nary Microbiology and Preventive Medicine, College of Veterinary
Medicine, Iowa State University, Ames, IA 50011. Phone: (515) 294-
3534. Fax: (515) 294-8500. E-mail: lknolan@iastate.edu.
† Present address: Department of Veterinary Molecular Biology,
Montana State University, Bozeman, MT 59718.
 Published ahead of print on 5 September 2006.
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food, such as poultry (21, 24, 39), two assays of urovirulence,
namely, growth in human urine (40) and a murine model of
ascending urinary tract infection (UTI) (22), were also used to
assess these organisms.
(This research was done by Jerod A. Skyberg in partial
fulfillment of the requirements for the Ph.D. degree from
North Dakota State University, Fargo, 2006.)
MATERIALS AND METHODS
Media and bacterial strains. All bacterial strains were stored in brain heart
infusion broth (Difco Laboratories, Detroit, MI) with 20% glycerol at 80°C
prior to use (42). In preparation for amplification, bacterial strains were grown
on either MacConkey or nutrient agar (Difco) overnight at 37°C. E. coli strains
and plasmids used in this study (Table 1) included APEC O2, isolated from the
joint of a chicken with colibacillosis and the original source of pAPEC-O2-ColV
and pAPEC-O2-R (27); UPEC HE300 (kindly provided by Soren Schubert at the
Max von Pettenkofer Institut), isolated from a human case of acute pyelonephri-
tis (50); TC, a transconjugant produced from the mating of APEC O2 and E. coli
DH5 (27); NC, isolated from the feces of an apparently healthy chicken, which
is of low virulence to chicken embryos (44); and the transconjugant, NC/pAPEC-
O2, produced from mating TC with NC.
Conjugation protocol. Transconjugants were produced using techniques de-
scribed previously (31). The plasmid donor strain used was TC, which is a
transconjugant itself. Use of TC as the intermediate donor of pAPEC-O2 plas-
mids facilitated identification of transconjugants, as TC does not ferment lactose,
whereas APEC O2 and the recipient NC do. TC contains pAPEC-O2-ColV and
pAPEC-O2-R (26, 27), both of which were previously transferred into TC from
the original donor strain, APEC O2 (27). To obtain the transconjugant, 0.2 ml of
an exponentially grown culture of TC was mixed with 1.8 ml of an overnight
culture of NC in antibiotic medium 3 broth (Difco). Mixtures were incubated
without shaking at 25°C, 37°C, and 42°C for 18 h. Transconjugants were selected
by their ability to resist streptomycin (65 g/ml; Amresco, Solon, OH) (TC
inhibiting) and ampicillin (100 g/ml; Amresco) (NC inhibiting). Ampicillin
resistance was chosen for transconjugant selection, as pAPEC-O2-ColV cotrans-
fers with pAPEC-O2-R, which encodes resistance to ampicillin and other anti-
microbials (26). Presumptive transconjugant colonies (ampicillin and streptomy-
cin resistant) were picked from the selector plates, and their identities were
confirmed by plasmid profiles, genotypes, antimicrobial resistance patterns, and
the abilities to produce ColV and aerobactin.
Plasmid isolation. Plasmid DNA was harvested by the method of Wang and
Rossman (55). The DNA obtained was separated in 0.8% agarose gels using
horizontal gel electrophoresis.
Virulence genotyping. To determine whether test and control organisms con-
tained the pAPEC-O2-ColV-like virulence cluster, they were examined for
relevant constituent genes by using a previously described multiplex PCR assay
(44). Targets included iss, the increased serum survival gene (2); tsh, encoding a
temperature-sensitive hemagglutinin (35); iucC, a gene involved in aerobactin
synthesis (4); and cvi, the immunity gene of the ColV operon (13).
ColV production. Isolates were screened for ColV production using a modified
version (56) of the method of Fredericq (11). The controls included E. coli 23559
(American Type Culture Collection [ATCC], Rockville, MD), which does not
produce colicin and is sensitive to the action of colicins, and E. coli 23558
(ATCC), which elaborates ColV. Organisms to be tested were stab inoculated
into nutrient agar (Difco) and incubated overnight at 37°C. Organisms were
killed by inverting the plates over chloroform-soaked filter paper for 30 min.
Then, 10 ml of half-strength nutrient agar, containing the indicator organisms, E.
coli 23559 and E. coli ATCC 23561 (56), was poured over the chloroform-killed
colonies. Plates were incubated overnight at 37°C and examined for zones of
growth inhibition of the indicator organism around the test stabs.
Aerobactin production. Isolates were also assessed for aerobactin production
as described by Vidotto et al. (54). Low-iron agar assay plates, composed of M-9
minimum salts, containing 200 M 2,2-dipyridyl (Sigma, St. Louis, MO) and
0.2% glucose (Sigma), were seeded with 1 ml/liter of an overnight culture of the
indicator organism, E. coli LG1522, which is incapable of producing aerobactin
but can use exogenously produced aerobactin. APEC O2, NC, NC/pAPEC-O2,
a known aerobactin-producing organism (E. coli LG1315), and a negative-con-
trol organism (E. coli HB101 [ATCC 33694]), were stab inoculated into the agar,
and the plates were incubated at 37°C for 24 h. Following incubation, plates were
observed for growth of the indicator organism around the stabs as evidence of
aerobactin elaboration by the test isolates.
Virulence assays. (i) Embryo lethality assay. Strains APEC O2, NC, and
NC/pAPEC-O2 were assessed for lethality in chicken embryos by inoculation of
overnight-washed bacterial cultures (500 CFU [CFU]) into the allantoic cavi-
ties of 12-day-old, embryonated, specific-pathogen-free eggs (32). Phosphate-
buffered saline-inoculated and -uninoculated embryos were used as controls.
Embryo deaths were recorded for 4 days.
(ii) Growth in human urine. Strains APEC O2, NC, and NC/pAPEC-O2 were
compared by their ability to grow in human urine, as described elsewhere (40).
Human UPEC strain HE300 was also included in this assessment (50). Urine
samples from five volunteers (who were healthy, not taking antibiotics, and
reported never experiencing a UTI) were collected, individually filter sterilized
with 0.2-m filters, pooled, and stored at 20°C. The strains to be tested were
grown overnight in 2 ml of Luria-Bertani (LB) broth. The next day, the cell
density was estimated by spectrophotometry, and cultures were diluted in phos-
phate-buffered saline prior to inoculation (100 l of inoculum into 4.9 ml of
urine) to achieve an approximate starting concentration of 102 to 103 CFU per
ml, which was confirmed by viable counts (this concentration of bacteria repre-
sents the lower end of what is considered a significant indicator of UTI in
symptomatic young women [51]). Mixtures were incubated at 37°C with shaking,
and aliquots were removed at set intervals for determination of viable counts.
Results were analyzed as the average of three trials.
(iii) Mouse UTI assay. A competition model of ascending murine UTI was
used, as previously described (22). Female CBA/J mice were anesthetized and
inoculated via the urethra under non-reflux-inducing conditions with a mixture
containing approximately equal concentrations of E. coli strains NC and NC/
pAPEC-O2, each of which had been grown individually overnight in LB broth at
37°C. The challenge inocula contained 2  109 total CFU, which is standard in
use of this model (22). After 48 h, mice were euthanatized, and urine samples
and their bladders and kidneys were collected sterilely. Organ homogenates and
urine samples were cultured quantitatively on agar with or without ampicillin to
determine the relative proportions of the strains. Additionally, from each posi-
tive culture, a representative colony (as available) was subjected to PCR analysis
TABLE 1. Phenotypic characteristics of E. coli strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s)a Source and/or reference
Strains
HE300 Positive control for growth in urine Human UTI (50)
TC Donor of pAPEC-O2-ColV and pAPEC-O2-R; is Sts Lac K-12 strain (27)
NC Low virulence to chicken embryos; is Str Lac; lacks iss, tsh, and the aerobactin, ColV,
and iro operons
Healthy chicken (44)
NC/pAPEC-O2 Transconjugant produced by the mating of TC and NC; contains pAPEC-O2-ColV
and pAPEC-O2-R; Str Lac
This study
APEC O2 Virulent to chicken embryos; original source of pAPEC-O2-ColV and pAPEC-O2-R Diseased chicken (27)
Plasmids
pAPEC-O2-ColV ColV plasmid of APEC O2; contains iss, tsh, and traT genes, along with the
aerobactin, ColV, sit and iro operons
27
pAPEC-O2-R R plasmid encoding resistance to multiple antimicrobials 26
a Abbreviations: Str, streptomycin resistant; Sts, streptomycin sensitive; ColV, colicin V; Lac, lactose fermentation.
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for one or more of the constituent virulence genes of pAPEC-O2-ColV to
provide molecular confirmation of plasmid content and strain identity. Dual-
strain challenges were used to compare the colonizing abilities of strains NC and
NC/pAPEC-O2, as intra-animal competition assessments minimize the impact of
mouse-to-mouse variation and maximize the ability to identify differences among
test strains (22). Colonies from the cultures were similarly analyzed to define the
relative abundance of the two test strains, and this proportion (the input ratio)
was used to adjust the postmortem quantitative culture results (the output ratio)
from the mouse infection experiments to obtain the competitive index.
Biostatistics. Differences in embryo lethality among the strains were evaluated
for statistical significance using a two-sample test of proportions (47). The
growth rate of each E. coli strain was determined as described previously (3, 10).
All data were included from the point at which the cell concentration had
increased to 150% of the inoculated concentration to the point at which the
population density ceased to increase. Urine growth rate data were analyzed
using linear regression analysis (Systat, Evanston, IL) to determine the specific
growth rate for each strain. Differences among the mean growth rates were
determined by using analysis of variance to place the strains into classes on the
basis of growth rates (SAS Institute). Differences in colonization abilities as
determined by the mouse UTI model were assessed as the proportion of positive
cultures (by site) in which, according to the competitive index, either test strain
outcompeted the other (with McNemar’s test used for significance testing). The
criterion for statistical significance was a P of 0.05.
RESULTS
Creation of transformant NC/pAPEC-O2. A fecal commen-
sal E. coli isolate (strain NC) from an apparently healthy chicken
was chosen as the recipient strain for these studies, since it was
known to be of low virulence to chicken embryos (44) and it lacks
the traits and genes known to be associated with pAPEC-O2-
ColV (Table 1). By using standard procedures, strain NC was
mated with TC, a K-12 derivative that contains the two large
plasmids from an avian colibacillosis isolate, APEC O2. To verify
that NC had acquired pAPEC-O2-ColV through conjugation, the
presumptive NC transconjugant was compared to APEC O2 and
NC with respect to several traits associated with pAPEC-O2-
ColV and pAPEC-O2-R. Consistent with its being a transconju-
gant, NC/pAPEC-O2 was found to contain a 180-kb plasmid
of the size of pAPEC-O2-ColV and to have acquired all the
pAPEC-O2-ColV-associated traits assessed, namely, iss, tsh, iucC,
cvi, and the abilities to produce ColV and aerobactin. Strain
NC/pAPEC-O2 had also acquired ampicillin resistance and a
101-kb plasmid, consistent with cotransfer of the large R plasmid
of donor strain APEC O2, i.e., pAPEC-O2-R (Table 1). In no
case did we find a transconjugant containing only pAPEC-O2-R
or pAPEC-O2-ColV, possibly because transconjugants contain-
ing both of the plasmids were selected for by the conditions used
in our mating procedure. Transconjugants containing the R plas-
mid were selected for by plating the mating mixture on plates
containing ampicillin. In addition, strain NC is sensitive to colicin
V (data not shown); therefore, it is possible that all the recipient
colonies that survive are those that have acquired the colicin V
plasmid (and colicin V immunity), as the colicin V-sensitive
recipient cells are eliminated by the action of colicin V that is
produced by the plasmid donor in the mating mixture.
Virulence assessment of strain NC/pAPEC-O2. Three differ-
ent assay systems, i.e., chicken embryo lethality, growth in human
urine, and a murine model of ascending UTI, were used to com-
pare the virulence of the transconjugant with that of its parents
and human UPEC strain HE300. Acquisition of pAPEC-O2-
ColV and pAPEC-O2-R by NC was associated with a significantly
increased ability to kill chicken embryos (Table 2). That is, strain
NC (lacking pAPEC-O2-ColV and pAPEC-O2-R) killed only 10
(15%) of 66 embryos, whereas the transformant NC/pAPEC-O2
killed 41 (62%) of 66 embryos (P  0.0001). Further, the differ-
ence in embryo lethality between NC/pAPEC-O2 and APEC O2
was not statistically significant.
FIG. 1. Growth of E. coli strains in urine. Strains APEC O2 (the source of the plasmids of interest), recipient E. coli strain NC, the
transconjugant NC/pAPEC-O2, and UPEC HE300 were studied. Growth curves were determined by measuring viable counts (CFU ml1) and
represent an average of three trials for each strain.
TABLE 2. Abilities of E. coli strains to cause chicken embryo
lethality 4 days postinfection
Strain No. ofembryos
No. of
deaths
P valuea
NC APEC O2
NC 66 10 0.001
APEC O2 64 48 0.001
NC/pAPEC-O2 66 41 0.001 	0.10
a P value of the number of deaths caused by E. coli strains compared to the
values for strains NC and APEC O2 calculated by using a two-sample test of
proportions (47).
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In human urine, strain NC/pAPEC-O2 grew significantly
faster than did strain NC (P  0.05) but did not attain the
growth rate of APEC O2, which was statistically indistinguish-
able from that of human UPEC strain HE300 (Fig. 1 and Table
3). In contrast, no differences in growth rates in LB broth were
evident for strains NC, APEC O2, NC/pAPEC-O2, and HE300
(Fig. 2).
Finally, the abilities of strains NC and NC/pAPEC-O2 to
colonize the murine urinary tract were compared (Table 4).
NC outcompeted NC/pAPEC-O2 in six of eight urine samples
(not statistically significant) and 12 of 15 bladders (P 
 0.035).
However, the transconjugant outcompeted the recipient in 17
of 18 culture-positive kidneys (P  0.001).
DISCUSSION
Since large plasmids appear to be one of the most common
features of APEC and may be a defining characteristic of the
APEC pathotype (37), this study sought to determine the roles
of two large, cotransferring APEC plasmids in virulence using
several models. We found that acquisition of pAPEC-O2-ColV
and pAPEC-O2-R by an avian commensal E. coli strain (NC)
was accompanied by enhanced abilities to kill chicken em-
bryos, grow in human urine, and colonize the murine kidney.
When E. coli NC/pAPEC-O2 was tested in chicken embryos,
it killed significantly more embryos than NC, whereas the dif-
ference in the proportion of embryos killed by NC/pAPEC-O2
versus wild-type strain APEC O2 was not statistically signifi-
cant. Although we feel it is likely that this increase in virulence
was due to acquisition of pAPEC-O2-ColV, interpretation of
these results must be tempered by the fact that NC/pAPEC-O2
also contains a second APEC-derived plasmid, pAPEC-O2-R,
that is absent from strain NC (26). Sequence analysis of this
second cotransferring plasmid has shown that it lacks the clus-
ter of putative virulence genes associated with pAPEC-O2-
ColV (26, 27), suggesting that the enhanced virulence of NC/
pAPEC-O2 may be due to acquisition of pAPEC-O2-ColV and
not to pAPEC-O2-R. These results suggest that, in a suitable
background, pAPEC-O2-ColV is a virulence plasmid that may
contribute to the pathogenesis of E. coli infections in poultry.
Such results are similar to what Smith found when transferring
ColV plasmids into avirulent recipients (46). Others have also
reported large plasmids in avian E. coli strains (7, 14, 25, 52),
and it appears that genes localized to pAPEC-O2-ColV are
widespread among APEC (37). Therefore, ColV plasmids
similar to pAPEC-O2-ColV may be important contributors to
APEC virulence generally. Also, of interest is the association
of these pAPEC-O2-ColV-like plasmids with large, cotransfer-
ring R plasmids, such as pAPEC-O2-R. This association may
TABLE 3. Growth of E. coli strains in human urine
Strain Mean growth rate (SE) andstatistical significancea
NC...............................................................................0.507 (0.012) A
NC/pAPEC-O2..........................................................0.547 (0.007) B
APEC O2 ...................................................................0.633 (0.012) C
HE300.........................................................................0.623 (0.012) C
a The growth rate was calculated in log10 CFU per hour. Growth rates with the
same letter are not significantly different, whereas growth rates with different
letters are significantly different (P  0.05), calculated by one-way analysis of
variance (Fisher’s least significant difference).
FIG. 2. Growth of E. coli strains in LB broth. Strains APEC O2 (the source of the plasmids of interest), recipient strain NC, the transconjugant
NC/pAPEC-O2, and (human pyelonephritis isolate) UPEC HE300 were studied. Growth curves were determined by measuring viable counts
(CFU ml1) and represent an average of three trials for each strain.
TABLE 4. Comparative urovirulence of E. coli strains NC
and NC/pAPEC-O2 in mice
Site
cultured
Total no. of
samplesa
No. (%) of samples with the following
urovirulence patternb:
P valuec
NC/pAPEC-O2 	
NC
NC/pAPEC-O2 
NC
Urine 8 2 (25) 6 (75) 	0.10
Bladder 15 3 (20) 12 (80) 0.035
Kidney 18 17 (94) 1 (6) 0.001
a Cultures were unavailable for 7 urine and 12 kidney samples.
b Number of samples that were colonized more strongly by strain NC than by strain
NC/pAPEC-O2 (NC/pAPEC-O2  NC) or vice versa (NC/pAPEC-O2 	 NC).
c P values of the numbers of samples with the urovirulence pattern shown by
McNemar’s test.
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provide an additional means by which APEC virulence plas-
mids are favored in nature. The relationship between R plas-
mid and virulence plasmids should be further examined, as
should the possible role of R plasmids in virulence.
Also of interest is the potential link that plasmids, such as
pAPEC-O2-ColV, provide between APEC and UPEC viru-
lence. For example, the iro operon located on pAPEC-O2-
ColV lies in close approximation to the iss gene (27), which is
similar to the arrangement described by Sorsa et al. for a
plasmid from a human UPEC strain (49). In fact, the reported
sequence around iss in the UPEC strain showed over 99%
identity with pAPEC-O2-ColV (GenBank accession number
AY567838). Additionally, pAPEC-O2-ColV shares certain
similarities in both sequence and gene arrangement with PAI
III of UPEC strain 536, which contains the iro operon, tsh, and
remnants of the ColV operon (6).
These similarities of pAPEC-O2-ColV to UPEC plasmids
and PAIs, as well as the documented transfer of APEC and
their plasmids from birds to human beings (28, 45), prompted
us to evaluate the potential contribution of pAPEC-O2-ColV
to urovirulence in a mammalian host. First, the growth of
strains NC/pAPEC-O2, APEC O2, NC, and UPEC HE300
(50) in human urine was compared, since Russo et al. (39)
reported that microbial growth in urine was a good predictor of
urovirulence and have used growth and gene expression in
urine to screen for potential urovirulence factors among E. coli
strains (40). Also, it is known that UPEC, compared to com-
mensal E. coli strains, show shorter lag periods and doubling
times when cultured in urine (15). The acquisition of pAPEC-
O2-ColV and pAPEC-O2-R by the recipient strain resulted in
a statistically significant increase in its growth rate in urine,
suggesting that acquisition of these plasmids was responsible
for the transconjugant’s enhanced ability to grow in urine. In
contrast, all of the strains grew at similar rates in LB broth,
indicating that the plasmids confer a growth advantage specific
to urine and are not a general growth promoter.
To further assess the potential of pAPEC-O2-ColV and
pAPEC-O2-R to contribute to urovirulence, the abilities of the
recipient and transconjugant to cause UTI in a mouse model
were compared. Although strain NC outcompeted the transcon-
jugant in colonization of the lower urinary tract (bladder), the
transconjugant significantly outcompeted the recipient to an even
greater extent in the kidney. These results suggest that the plas-
mids of strain APEC O2, most likely pAPEC-O2-ColV, have the
potential to contribute to the pathogenesis of upper UTI in mam-
malian hosts.
Although future experiments will be required to definitively
determine whether pAPEC-O2-ColV or pAPEC-O2-R is re-
sponsible for enhancing the disease-causing abilities of strain
NC in chicken embryos and mice, pAPEC-O2-ColV is the
more likely candidate. Several traits encoded by pAPEC-O2-
ColV may contribute to virulence, including the ability to resist
complement, a common characteristic among APEC and the
UPEC causing upper UTIs (5, 20, 33), and the ability to acquire
iron under limiting conditions, a characteristic associated with
both APEC and UPEC virulence (5, 20). For instance, the
aerobactin (4), iro (9), and sit operons, along with the iss and
tsh genes (GenBank accession number AY545598), have all
been found on pAPEC-O2-ColV (27). Interestingly, genes of
the aerobactin, sit, and iro operons along with the tsh gene were
upregulated in UPEC CFT073, an archetypical UPEC strain,
during growth in human urine or in the mouse urinary tract (19,
48). Further study of pAPEC-O2-ColV or related plasmids may
detect other candidate virulence genes contributing to the patho-
genesis of both avian colibacillosis and human UTI.
Although these results suggest that pAPEC-O2-ColV has
the potential to contribute to urovirulence, we did not deter-
mine whether E. coli strains containing pAPEC-O2-ColV-like
plasmids colonize human beings. However, genes associated
with pAPEC-O2-ColV are widely distributed among both
APEC and human UPEC strains (38). In addition, others have
demonstrated that plasmid-containing E. coli strains from
poultry may colonize human beings and that use of antimicro-
bials may facilitate this exchange (28, 29, 34, 53). Also, Levy
and coworkers (28) demonstrated that resistance plasmids and
the E. coli strains containing these plasmids could be trans-
ferred from chicken to chicken and from chickens to humans.
So too, evidence exists that this microbial transfer from birds
to human beings may involve potential human pathogens (24,
43). In addition, numerous recent studies have shown that
extraintestinal pathogenic E. coli strains (41), a group encom-
passing UPEC and APEC, are fairly common in retail poultry
(21, 23, 24). Therefore, it would seem that further study of
APEC plasmids is warranted, both for their contributions to
APEC virulence in poultry and for their potential to serve as
reservoirs of urovirulence genes of significance to human
health.
In summary, we used an avian fecal E. coli recipient strain to
study the contributions of certain APEC plasmids to virulence.
Although further work will be required to draw definitive con-
clusions about the roles of these plasmids in virulence, it is
likely that these plasmids enable commensal E. coli strain NC
to kill chicken embryos, suggesting that it plays a role in the
pathogenesis of avian colibacillosis. Also, the transconjugant’s
enhanced ability to grow in urine and cause upper UTIs in
mice suggest that APEC plasmids are capable of contributing
to urovirulence in mammalian hosts. Together with their doc-
umented ability to transfer to human beings, the results of this
study suggest that APEC plasmids could serve as reservoirs of
urovirulence genes for E. coli that cause UTIs in humans.
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